CorMedix Inc.
Symbol: CRMD (NASDAQ)
12.74
▼ (-2.24%) -0.292
Company Description:
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Key Stats
- Today's Open: $12.96
- Today's High: $13.449
- Today's Low: $12.71
- Today's Volume: 3.33M
- Yesterday Close: $13.03
- Yesterday High: $13.83
- Yesterday Low: $12.79
- Yesterday Volume: 5.02M
- Last Min Volume: 0
- Last Min High: $12.94
- Last Min Low: $12.94
- Last Min VWAP: $0
Company Profile
- Name: CorMedix Inc.
- Website: https://www.cormedix.com
- Listed Date: 2010-05-13
- Location: BERKELEY HEIGHTS, NJ
- Market Status: Active
- CIK Number: 0001410098
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $951.77M
- Round Lot: 100
- Outstanding Shares: 74.65M
- Asset Type: CS
RECENT FILINGS FOR CRMD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-09-08 | 4/A | View |
| 2025-09-08 | 4/A | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 3 | View |
| 2025-09-03 | 144 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-12 | 8-K | View |
| 2025-08-08 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-30 | 424B5 | View |
| 2025-06-26 | 424B5 | View |
| 2025-06-25 | 8-K | View |
| 2025-06-23 | 8-K | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
Latest News on CRMD